Status:
COMPLETED
Evaluation of Endoplasmic Reticulum Stress in Patients With Recurrent Pregnancy Loss
Lead Sponsor:
Kanuni Sultan Suleyman Training and Research Hospital
Conditions:
Recurrent Pregnancy Loss
Endoplasmic Reticulum Stress
Eligibility:
FEMALE
18-45 years
Brief Summary
To evaluate endoplasmic reticulum stress in women with recurrent pregnancy loss and those who had healthy births in the same age group. The level of the unfolded protein X box binding protein 1 (XBP-1...
Eligibility Criteria
Inclusion
- with three or more miscarriages before 20 th week of gestation
- had no chronic or acute inflammatory disease
- used no steroids, anti-inflammatory, or antioxidant medications
Exclusion
- had inflammatory diseases
- had systemic disease
- Anatomical abnormalities, infectious, endocrine, or genetic etiologies
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 7 2020
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04455256
Start Date
March 20 2020
End Date
July 7 2020
Last Update
July 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pinar Yalcin Bahat
Istanbul, İ̇stanbul, Turkey (Türkiye), 34000